Molecular Epidemiological Study of Thyroid Disease in Radiation Contaminated Area
辐射污染地区甲状腺疾病的分子流行病学研究
基本信息
- 批准号:15256004
- 负责人:
- 金额:$ 22.38万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In this study, our group is participating in International Chernobyl Tissue Bank Project, which stocks and manages nuclear acids extracted from Chernobyl childhood thyroid cancer tissues for research purpose. We collaborate international medical care with Medical Radiological Research Centre, Russian Academy of Medical Sciences (Russian Federation), Belarusian Medical University (Republic of Belarus), Research Center for Radiation Medicine of the Academy of Medical Sciences of Ukraine (Ukraine) and Research Institute for Radiation Medicine and Ecology (Republic of Kazakhstan). We accepted and trained 18 research scientists from these collaboration Universities and Institutes in our institute during last three years. We established telemedicine and teleeducation system between Gomel Medical University (Republic of Belarus) and our institute to give lectures to medical students in Gomel Medical University. Our group also visited Gomel and Minsk for three weeks every year to take the helm on molecular epidemiological study and e-Learning system. We analyzed mitochondria DNA and genomic DNA extracted from Chernobyl childhood thyroid cancer tissues to find radiation signatures left in the DNA. As the results, we found large deletion of mitochondria DNA and unique SNPs sites in DNA repair related genes including TP53, ATM and MDM2 genes in radiation associated thyroid cancers. Through this study, we found new findings of radiation associated thyroid cancer and promoted international exchanges regarding scientific research and educations. We hope further extending studies in this field.
在这项研究中,我们的小组正在参与国际切尔诺贝利组织库项目,该项目储存和管理从切尔诺贝利儿童甲状腺癌组织中提取的核酸用于研究目的。我们与医学放射研究中心,俄罗斯医学科学院(俄罗斯联邦),白俄罗斯医科大学(白俄罗斯共和国),乌克兰医学科学院放射医学研究中心(乌克兰)和放射医学和生态研究所(哈萨克斯坦共和国)合作开展国际医疗服务。在过去的三年里,我们接受并培训了来自这些合作大学和研究所的18名研究科学家。我们在戈梅利医科大学(白俄罗斯共和国)和我们的研究所之间建立了远程医疗和远程教育系统,为戈梅利医科大学的医学生提供讲座。我们的团队还每年访问戈梅利和明斯克三周,负责分子流行病学研究和电子学习系统。我们分析了从切尔诺贝利儿童甲状腺癌组织中提取的线粒体DNA和基因组DNA,以寻找DNA中留下的辐射特征。结果发现,在放射相关甲状腺癌中存在线粒体DNA的大量缺失和DNA修复相关基因TP53、ATM和MDM2的独特SNPs位点。通过本研究,我们发现了辐射相关甲状腺癌的新发现,促进了国际科研和教育交流。我们希望在这一领域的研究能进一步扩大。
项目成果
期刊论文数量(118)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area and its correlation with Pin1 and aberrant beta-catenin expression.
放射性污染区域的甲状腺肿瘤中 Cyclin D1 过度表达及其与 Pin1 和异常 β-catenin 表达的相关性。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Ahmed;A.M.;Shinoda;S.;Shimamoto;T.;Nakashima M 他
- 通讯作者:Nakashima M 他
Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers
- DOI:10.1210/jc.2003-030305
- 发表时间:2003-09-01
- 期刊:
- 影响因子:5.8
- 作者:Namba, H;Nakashima, M;Yamashita, S
- 通讯作者:Yamashita, S
A.Podtcheko, et al.: "The selective tyrosin kinase inhibitor, ST1571, inhibits the growth of anaplastic thyroid cancer cells"J.Clin.Endocrinol.Metab.. 88. 1889-1896 (2003)
A.Podtcheko 等人:“选择性酪氨酸激酶抑制剂 ST1571 抑制未分化甲状腺癌细胞的生长”J.Clin.Endocrinol.Metab.. 88. 1889-1896 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Cyclin D1 overexpression in thyroid papillary microcarncinoma : its association with tumour size and aberrant beta-catenin expression.
甲状腺乳头状微小癌中细胞周期蛋白 D1 过度表达:与肿瘤大小和异常 β-连环蛋白表达的关系。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Lantsov D;et al.
- 通讯作者:et al.
The BRAF^<T1796A> transversion is a prevalent mutational event in human thyroid microcarcinoma.
BRAF^<T1796A>颠换是人类甲状腺微小癌中常见的突变事件。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Yugo Nomura;Satoshi Nakai;Masaaki Hosomi;I.Sedliarou et al.
- 通讯作者:I.Sedliarou et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAMBA Hiroyuki其他文献
NAMBA Hiroyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAMBA Hiroyuki', 18)}}的其他基金
Thrombomodulins's effects in ocular tissue and their clinical administration.
血栓调节蛋白对眼组织的影响及其临床给药。
- 批准号:
23791964 - 财政年份:2011
- 资助金额:
$ 22.38万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
In vivo model mouse study to examine the effect of alteration of endogenous endocrine status in thyroid tumorigenesis
体内模型小鼠研究探讨内源性内分泌状态改变对甲状腺肿瘤发生的影响
- 批准号:
18591030 - 财政年份:2006
- 资助金额:
$ 22.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Thyroid cancer study for establishment of prognostic marker and molecular targeting therapy using gene mutation analysis.
使用基因突变分析建立预后标志物和分子靶向治疗的甲状腺癌研究。
- 批准号:
15590981 - 财政年份:2003
- 资助金额:
$ 22.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Comprehensive Study of Carcinogemesis and Molecular Target Therapy in Thyroid Cancer
甲状腺癌致癌与分子靶向治疗的综合研究
- 批准号:
15390295 - 财政年份:2003
- 资助金额:
$ 22.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Competitive analysis of radiation induced gene expression between thyroid cell and fibroblast
甲状腺细胞与成纤维细胞辐射诱导基因表达的竞争分析
- 批准号:
09680529 - 财政年份:1997
- 资助金额:
$ 22.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic study for genetic therapy by analysis of intracellular signal transduction in thyroid carcinoma cell
甲状腺癌细胞胞内信号转导分析的基因治疗基础研究
- 批准号:
06671039 - 财政年份:1994
- 资助金额:
$ 22.38万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Analysis of signal transduction in thyroid cancer cell
甲状腺癌细胞信号转导分析
- 批准号:
04671490 - 财政年份:1992
- 资助金额:
$ 22.38万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Exploration of biomarkers based on genomic information and tumor immune microenvironment of thyroid cancer
基于甲状腺癌基因组信息和肿瘤免疫微环境的生物标志物探索
- 批准号:
23K19516 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
A Pilot Feasibility Study of an Intervention to Decrease Overtreatment of Low-risk Thyroid Cancer
减少低危甲状腺癌过度治疗的干预措施试点可行性研究
- 批准号:
10729147 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Targeting Ferroptosis in BRAF (V600E) Mutant Anaplastic Thyroid Cancer
靶向 BRAF (V600E) 突变型甲状腺未分化癌中的铁死亡
- 批准号:
10721967 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Cancer-associated fibroblasts promote thyroid cancer malignancy through Wnt signaling
癌症相关成纤维细胞通过 Wnt 信号传导促进甲状腺癌恶性
- 批准号:
10677942 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
The Effect of WTC Exposure on Thyroid Cancer in the Survivor Population
WTC 暴露对幸存者人群甲状腺癌的影响
- 批准号:
10749691 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Elucidation of molecular mechanisms of occurrence of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
23K08067 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer
碘难治性甲状腺癌个体化再敏化的新方法
- 批准号:
10612661 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
The development of a technology-based information support intervention (iSupport) among patients with differentiated thyroid cancer post radioactive iodine therapy
针对放射性碘治疗后分化型甲状腺癌患者开发基于技术的信息支持干预 (iSupport)
- 批准号:
10581121 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Wnt Signaling in the Development of Aggressive Thyroid Cancer
Wnt 信号转导在侵袭性甲状腺癌发展中的作用
- 批准号:
10385266 - 财政年份:2022
- 资助金额:
$ 22.38万 - 项目类别: